Use of drugs in myopathies.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003882:Dermatomyositis / Q000188:drug therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D006947:Hyperkalemia / Q000188:drug therapy; D006996:Hypocalcemia / Q000188:drug therapy; D007008:Hypokalemia / Q000188:drug therapy; D007010:Hyponatremia / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009135:Muscular Diseases / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D009136:Muscular Dystrophies / Q000188:drug therapy; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000601:surgery; D009220:Myositis / Q000139:chemically induced / Q000188:drug therapy; D013934:Thymectomy
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D000991:Antithrombins; D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone